Sign Up to like & get
recommendations!
0
Published in 2017 at "Toxicological Sciences"
DOI: 10.1093/toxsci/kfx062
Abstract: Several endothelin receptor antagonists (ERAs) have been developed for the treatment of pulmonary arterial hypertension (PAH). Some of them have been related to clinical cases of hepatocellular injury (sitaxentan [SIT]) and/or cholestasis (bosentan [BOS]). We…
read more here.
Keywords:
mechanisticinsights cytotoxic;
heparg cells;
cover mechanisticinsights;
receptor antagonists ... See more keywords